Company intelligence / Profile preview
Pharmex Group
- Ownership
- Private
- Development stage
- Other
Overview
Pharmex Group is an active international pharmaceutical company focused on the development, manufacturing, and marketing of prescription drugs (Rx), over-the-counter medicines (OTC), medical devices, and nutrition products. It operates globally with a strong presence in Europe, the Middle East & Africa (MEA), and Latin America. The company has a particular emphasis on infant nutrition through its Tebramil® brand. Its manufacturing capabilities include both small molecules and immunobiologicals
- Therapeutic areas
- Other
- Modalities
- Small moleculeBiologic (immunobiological products)
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Pharmex Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pharmex Group.